A review of cardiac involvement in COVID-19 infection

Afshar, Zeinab Mohseni; Babazadeh, Arefeh; Javanian, Mostafa; Ramezani, Elham; Shemshadi, Reyhaneh; Ebrahimpour, Soheil

doi:10.33678/cor.2020.102

Cited by 6 publications

(9 citation statements)

References 55 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…4,5 Instead, in the case-series by Bangalore and colleagues, patients with acute myocardial infarction and COVID-19 infection had different clinical as well as angiographic presentations. 6,7 Indeed, the mean age of the patients was 63 years and most of them suffered from hypertension and diabetes mellitus. In addition, in 33% of patients at coronarography the coronary arteries were angiographically normal.…”

Section: Discussionmentioning

confidence: 99%

“…The multitude of pathways involved in the pathophysiology of myocardial infarction in COVID-19 infection results in a complex diagnostic and therapeutic management. 7,10,11 Thus, the European Society of Cardiology developed Guidance for the Diagnosis and Management of Cardiovascular Disease during the COVID-19 Pandemic to guide the cardiologist's choices balancing the exposure of the health professional with the benefi t to the patient.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Post‑infectious acute myocardial infarction following COVID‑19 infection in a young patient

Caminiti¹,

Vetta²,

Parlavecchio³

et al. 2023

Cor Vasa

View full text Add to dashboard Cite

Dnes je již dobře známo, že onemocnění covid-19 může mít i různé extrapulmonální projevy. Mezi možné mechanismy postižení kardiovaskulárního systému patří přímé poškození myokardu v důsledku hyperkoagulability vyvolané systémovým zánětem, což může vyústit i v destabilizaci plátů v koronárních tepnách. Popisujeme případ 30letého mladého muže po asymptomatickém onemocnění covid-19, který byl přijat na oddělení akutních příjmů nemocnice Grande Ospedale Metropolitano di Reggio Calabria (Itálie) s typickou bolestí na hrudi. U pacienta nebyla stanovena diagnóza kardiovaskulárního onemocnění, nebyly přítomny žádné rizikové faktory, ani kardiovaskulární onemocnění v rodinné anamnéze. Urgentní koronarografi e prokázala kritickou (80%) stenózu ve střední a proximální části r. interventricularis anterior tvořenou plátem vzhledu ateromového vředu. Naše kazuistika upozorňuje na nutnost -bez ohledu na rizikové faktory kardiovaskulárního onemocnění -ověřit přítomnost či nepřítomnost onemocnění covid-19 u všech pacientů s akutním infarktem myokardu během této pandemie.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Post‑infectious acute myocardial infarction following COVID‑19 infection in a young patient

Caminiti¹,

Vetta²,

Parlavecchio³

et al. 2023

Cor Vasa

View full text Add to dashboard Cite

show abstract

“…As this relates to the COVID-19 pandemic and stress cardiomyopathy, there was a case report on two elderly Hispanic patients. The first patient suffered from anxiety leading her to presenting of heart failure symptoms; the second patient developed stress cardiomyopathy due to increased emotional stress as an indirect consequence of the ongoing pandemic [15].…”

Section: Cardiomyopathymentioning

confidence: 99%

Excess Body Mass—A Factor Leading to the Deterioration of COVID-19 and Its Complications—A Narrative Review

Gryczyńska

Litvinov

Bitew

et al. 2021

Viruses

View full text Add to dashboard Cite

Currently, the world is facing two serious pandemics: obesity and COVID-19. It is well-established that the prevalence of obesity has risen dramatically, causing a deterioration in the health quality of the population and increasing susceptibility for the unfavourable course of acute infections. It has been observed that excess body mass significantly influences the COVID-19 outcome. The aim of this review is to present the latest scientific reports on the impact of excess body mass on the course and complications of COVID-19. The Web of Science, PubMed, and Google Scholar databases were searched. Only studies reporting patients stated to be COVID-19 positive based on the results of a nasopharyngeal swab and the ribonucleic acid test were included. It is shown that thromboembolic and ischemic complications, namely stroke, disseminated intravascular coagulation, severe hyperglycaemia, and leukoencephalopathy are more likely to appear in COVID-19 positive patients with obesity compared to non-obese subjects. COVID-19 complications such as cardiomyopathy, dysrhythmias, endothelial dysfunction, acute kidney injury, dyslipidaemia, lung lesions and acute respiratory distress syndrome have a worse outcome among obese patients.

show abstract

“…Furthermore, there have been reports of different kinds of micro‐ or macro‐vasculature emboli in the present pandemic, including arterial and venous thrombosis. The hypercoagulable state brought on by this viral infection has almost always resulted in serious side effects, such as neurological and cardiac problems 4–6 …”

Section: Introductionmentioning

confidence: 99%

Anticoagulant therapy in COVID‐19: A narrative review

Afshar

Pirzaman

Hosseinzadeh

et al. 2023

Clinical Translational Sci

Self Cite

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID‐19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), can manifest itself in several ways, including coagulopathy and thrombosis. These complications can be the first and sometimes only manifestations of SARS‐CoV‐2 infection and can occur early or late in the course of the disease. However, these symptoms are more prevalent in hospitalized patients with venous thromboembolism, particularly those admitted to intensive care units. Moreover, various forms of arterial and venous thrombosis, or micro‐ or macro‐vasculature embolisms, have been reported during the current pandemic. They have led to harmful consequences, such as neurological and cardiac events, nearly all resulting from the hypercoagulable state caused by this viral infection. The severe hypercoagulability observed in patients with COVID‐19 accounts for most cases of the disease that become critical. Therefore, anticoagulants seem to be one of the most vital therapeutics for treating this potentially life‐threatening condition. In the current paper, we present a thorough review of the pathophysiology of COVID‐19‐induced hypercoagulable state and the use of anticoagulants to treat SARS‐CoV‐2 infections in different patient groups, as well as their pros and cons.

show abstract

A review of cardiac involvement in COVID-19 infection

Cited by 6 publications

References 55 publications

Post‑infectious acute myocardial infarction following COVID‑19 infection in a young patient

Post‑infectious acute myocardial infarction following COVID‑19 infection in a young patient

Excess Body Mass—A Factor Leading to the Deterioration of COVID-19 and Its Complications—A Narrative Review

Anticoagulant therapy in COVID‐19: A narrative review

Contact Info

Product

Resources

About